XOMA CORPORATION (NASDAQ:XOMA) Files An 8-K Other EventsItem 8.01.
On May 16, 2017, XOMA Corporation (“XOMA”) received notice from Novartis International Pharmaceutical Ltd. (“Novartis”) that Novartis achieved a clinical development milestone to the License Agreement by and between XOMA and Novartis dated as of September 30, 2015, and, as a result, Novartis approved and will pay a $10.0 million milestone payment to XOMA.
XOMA CORPORATION (NASDAQ:XOMA) Recent Trading Information
XOMA CORPORATION (NASDAQ:XOMA) closed its last trading session up +0.18 at 6.49 with 50,219 shares trading hands.
